Author | Farhad Ravandi, MD | OncLive

Author | Farhad Ravandi, MD

Articles

Dr. Farhad Ravandi Discusses Vosaroxin in the VALOR Trial

December 07, 2014

Video

Farhad Ravandi, MD, from the University of Texas MD Anderson Cancer Center in Houston, describes results from the phase III VALOR trial that explored vosaroxin plus cytarabine versus placebo and cytarabine in patients with first relapsed or refractory acute myeloid leukemia.

Dr. Ravandi on Resistance in AML

March 04, 2014

Video

Farhad Ravandi, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses resistance in adults with acute myeloid leukemia.

x